Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That being said..kinda feel like I’m Moses and will have to wander the desert with my Namaste shares for forty years...lol
Same boat and same rationale..
Yeah it’s no secret that Chris Perry not a big Namaste fan...but he definitely acknowledges they’re righting the ship and should be fine going forward. It soo sad to see so many people actually think this massive business is going to disappear overnight...Let it drop some and reset and nothing to do at this point but hang on for the ride and we will be fine in the long run..
I like it shows business as usual. Everything else is just background noise. They had to get rid of Sean so they did. Cleaning up the books and trimming the fat, doing it. Nothing wrong with this company, they just had to take out the trash which has created another buying opportunity. It does suck when everyone thought we were about to take off but they just weren’t done cleaning house!
Well they leave us no choice, but to......load up!!
LOL..
Thats totally messed up since thats the very same day they issued company update press release about settling with deuschbag..? They should have lumped it all together instead of this continual bad news bs..kicking someone when they're already down.
1. PricewaterhouseCoopers LLP (PwC) resigned as auditor of the Corporation effective
February 19, 2019.
2. PwC resigned on its own initiative.
3. the resignation of PwC as auditor of the Corporation has been considered and approved by
the Board of Directors of the Corporation (the Board) and the audit committee of the Board.
4. PwC did not complete an audit of the Corporation since its appointment.
5. PwC has not been able to reach a conclusion as to whether a reportable event has occurred,
as such term is defined in NI 51-102.
DATED this 21st day of February, 2019.
NA
Yeah the cafe was a waste of time and money for sure. Shareholders are between a rock and hard place. Do you sell and take the big loss or hold and die a slow death, or have to hold for years for recovery..I know most spent the last year averaging down etc..No bueno!
Yeah, I thought Sean went away too quickly and quietly..This does not bode well for shareholders because they never give us all the information we need to make decisions, they alert us to actions without details. So basically as the pps continues to plummet people are going to want to sue the shite out of Dollinger...All we can say is FRUCK!! That stupid little bastard screwed up what could have been awesome. I think most will now take their losses and move on to lick their wounds and try to recoup somewhere else in the sector whilst its still hot!
No doubt! Wondering why there isn't alot more snap, crackle, pop going on...Freaking Aurora up .75 cents on nuttin, and yet here we wit atop this gold mine...countin chickens
Key Milestones - First Fully Licensed Extraction Company in Canada
Oct 4, 2018
“LABS” trades on TSX-V
Feb 21, 2019
1st international wholesale
with AusCann Export to Australia
Nov 14, 2018
3 yr. tolling signed
Dec 24, 2018
Health Canada approves expansion
Jan 8, 2019
Large tolling agreement signed
Feb 12, 2019
$35 million oil sale –
$7.5 million upfront
1 2 3 4 5 6 7 8 9 10 11
Nov 12, 2018
Sales Licence approved
Nov 29, 2018
900 kg/18 month extract agreement
Jan 7, 2019
“MLCPF” trades on OTCQB
Jan 16, 2019
$10 million sales
in 1st month
Feb 12, 2019
$85 million projected revenue/15 months
Not too shabby for a couple months in business....Execution!
We are all at the praise festival for Park...Gonna have to bust out the defibrillator on this one.....
Another gift from the Ianthus gods....Nothing but blues skies ahead for this awesome company..Buy all you can and hold on!
$$Boom...Shares just appeared in my Fidelity account!!
Hey hey..quit eye balling my woman!! lol
The best part is they already inked a half dozen deals before the big deal and Auscan...and nobody has any idea how lucrative they are since they haven't given any financial details until the big one. I think when people see the numbers there is going to be an oh shite moment and then blastoff!
Ugh...Me either. I thought their Italy partner was supposed to be the goods with all the products? We need more info on company direction, if they think they are just gonna grow a bunch of hemp...well so is everyone else.
"I didn't know they made 9th place ribbons."....lol
Hey Mono. Glad you were able to find the Pharm..Having you here just reiterates that warm and fuzzy feeling I have about labs. I have no doubt that they will blow up. I have been following them since their inception and they have executed flawlessly, which is extremely difficult to do in this rapidly changing industry. We have not even begun to see what they will accomplish internationally, which is what they set up for since the beginning. They have always made a big deal about their international pharma standards and readiness!
I think its going to take something extra special to break us out of this trading range we have been stuck in for what seems like forever..but not really. Last time financials came out and were good it did nothing for the sp and when the farm bill passed unfortunately it also did nothing for the share price since the fda had not acted on anything yet?
I think alot of people thought there would be some sort of m&a or further notice on drug 007 which we have heard absolutely nothing about for awhile. So nothing to do but wait for up-list and after that things should all fall into place. People in the market are just so antsy nowadays..
It is very frustrating because first mover advantage only lasts so long, and its obvious every lp and mj company in the whole sector is jumping on the bandwagon, if everyone thinks the cbd market is crowded now...just wait till the the big companies start white labeling their products.
I have no doubt that financials will be stellar and uplist will happen...hopefully sooner than later!
Yeah the only problem is that they have been sitting on that 300 mil for almost a year and there is alot of m&a going on throughout the sector and Auxly is definitely not impressing anyone!
CV Sciences’ PlusCBD Oil™ Gold Softgels Named “Top Pick” by ConsumerLab.com
BY GlobeNewswire
— 8:45 AM ET 02/20/2019
Country’s top-selling hemp-derived CBD brand recognized for its purity and value; PlusCBD Oil™ products pass rigorous third-party quality testing for THC and heavy metals
LAS VEGAS, Feb. 20, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. ( CVSI
Loading...
Loading...
) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of industry-dominating hemp CBD brand, PlusCBD Oil™, today announced that its best-selling product, PlusCBD Oil™ Gold Softgels, has been named a “Top Pick” by ConsumerLab.com, LLC (CL), a leading provider of independent test results for the supplement industry. PlusCBD Oil™ Gold Softgels received this recognition based on the product’s industry-leading purity and value, as well as its label accuracy.
Additionally, CV Sciences ( CVSI
Loading...
Loading...
) announced that each of its hemp CBD products tested– including PlusCBD™ Oil Capsules, Balm, Softgels, Drops, Sprays and Gummies – have passed CL’s rigorous quality testing for CBD, which includes tests for THC and heavy metals.
“Considering the significant variations that have been shown in the amounts and quality of CBD in marketed products, we believe credible third-party analysis and certification is critical for establishing and maintaining customer trust,” said Joseph Dowling, Chief Executive Officer of CV Sciences ( CVSI
Loading...
Loading...
). “CV Sciences is committed to safety and integrity in all of our products, and we have gone the extra mile to ensure that PlusCBD Oil™ is the most innovative and highest quality CBD brand on the market. It is gratifying to see our hard work recognized by ConsumerLab, which maintains among the highest standards of any third-party group certifying the quality of dietary supplements.”
To conduct its test, CL purchased a sampling of popular products labeled to contain CBD, cannabinoids (other than THC), and/or hemp extracts, and tested them to determine the amount of CBD they contained compared to their labels. Products were also tested for contamination with lead, cadmium and arsenic, and then compared by label accuracy, quality and cost.
CV Sciences’ PlusCBD Oil™ is the top-selling brand of hemp-derived CBD in independent retail and ranked second in sales overall in the independent natural products retailer channel when combining all supplement categories, according to SPINS, the leading provider of data and insights for the natural, organic and specialty products industry. The Company’s natural product retail channel includes more than 2,000 locations nationwide and the Company expects the passage of the 2018 Farm Bill to result in significantly increased distribution across food, drug and mass (FDM) channel retailers, broadening exposure and availability of PlusCBD Oil™ to millions of U.S. consumers.
If you google namaste technologies the information box that pops up on rights side of the screen use to say founders Sean Dollinger, Kory. They didn't waste anytime erasing sd's name and now it just saws Founder=Kory.
Google Namaste Technologies and look what pops up....Founder..? Thought they might have taken him out back and put him out of his misery...lol
Namaste Technologies
Company
Image result for namaste technologies
namastetechnologies.com
Founder: Kory Zelickson
Founded: 2005
Headquarters: Toronto, Canada
Stock price: NXTTF (OTCMKTS) $0.84 +0.03 (+4.22%)
Feb 19, 11:04 AM EST - Disclaimer
Subsidiaries: CannMart Inc., VaporSeller, Findify AB, VapeBr, MORE
Just a little info to let all know that its business as usual...with happy customers....
https://www.trustpilot.com/review/namastevapes.co.uk
I'm sure it probably is due to the fact that like Dollinger said in his last Midas interview they were already in front of a judge right after pr and his lawyers were petitioning that proper procedure wasn't followed in the way that board moved and announcing they way they did. So basically just lawyers doing their thing filing petitions and Namaste has to go with the flow.
There is no conspiracy here, just business and its processes.
Agreed..when they finally come out with audited results and all the particulars we have all been waiting what seems like forever, then we will finally know and I'm pretty sure management knows its sink or swim time!
And they better have better then average results for us. Patient count better be astronomical, traffic counts and sales numbers better be stellar...etc
You all sound like a bunch of whiny girls. The whole show has only been up and running and legally allowed for 4 whole months....jeez. Don't care if website is made with crayons, being able to go to one website and be able to purchase anyone's product across the board will be the tits. Just needs a pinch of salt and a little time to marinate....
It’s totally ludicrous to think that whole company is going to stop functioning and collapse just because the inexperienced deuschbag ceo got chitcanned. We have an awesome sales platform in place and Namaste has been evolving very well within the mj space. I still think the skies the limit with this one. Patience will pay handsomely..
Easy tiger..Ianthus will be just fine, some peeps got shares and are ignorant investors just in the arbitration play. Ianthus is going to be a monster and is trading at less the half of its peers. We will be trading at $10-12 before you know it...and thats just the beginning, they have a license to print money!
Boys it looks like MediParm is our sleeper...gonna be hard to hide her in the shadows much longer, best load up if you haven’t already. They are executing flawlessly..$$
MediPharm Labs Signs $35 Million Private Label Cannabis Oil Sale Agreement with Option for Additional $13.5 Million
TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (“MediPharm”) a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to announce that its wholly-owned subsidiary, MediPharm Labs Inc. (“MediPharm Labs” or the “Company”), has entered into a significant sales agreement with a leading Licensed Producer to supply approximately $35 million of private label purified cannabis oil concentrates. Under the terms of the agreement, the Licensed Producer will immediately purchase upfront $7.66 million of cannabis oil concentrate from MediPharm Labs’ inventory in February 2019. In addition, the Licensed Producer will purchase a minimum of $27 million of cannabis oil concentrate over a 12-month period commencing March 2019, with an option to purchase an additional $13.5 million over the same period, bringing the total potential aggregate value of the agreement to over $48 million to February 2020.
MediPharm Labs’ private label program is a high margin business for the Company, whereby it opportunistically procures dry cannabis flower and trim from its thirteen product supply partners, to produce proprietary cannabis oil concentrate products for resale globally on a private label basis. This is MediPharm Labs’ fourth private label sales agreement to date. In total, these four agreements have aggregate potential value of over $85 million in the 15-month period that commenced December 2018.
“As the cannabis industry continues to rapidly grow and evolve, MediPharm Labs has quickly established itself as a dominant player and leading provider of private label cannabis oil concentrates to other Licensed Producers and branded product manufacturers. We have also demonstrated the permanent need for a specialized extraction provider to fulfill and secure the cannabis supply chain for medical and recreational consumers,” said Pat McCutcheon, CEO of MediPharm Labs. “With our significant first mover advantage, deep expertise, leading-edge proprietary technology to manufacture and develop high-quality cannabis oil and concentrate products at commercial scale, we have quickly been able to execute several major contracts already and continue to see robust demand for our specialized products and services and are well positioned to achieve strong revenue growth as a dominant extraction company in the cannabis industry.”
As an agnostic supplier of pharmaceutical grade cannabis oil concentrates to the global cannabis industry, MediPharm Labs has demonstrated its ability to strengthen and further secure the domestic supply chain for high-demand cannabis oil. This new supply agreement, combined with a large, long-term oil supply agreement previously announced with Canopy Growth Corporation, represents less than 10% of MediPharm Labs’ annual extraction capacity of 150,000 Kg, which is currently being expanded to 250,000 Kg of annual extraction capacity, with completion expected Q2 2019.
To date, MediPharm Labs has completed four private label wholesale agreements for cannabis oil concentrate supply (including Canopy Growth Corporation); five long-term cannabis concentrate program (tolling) agreements with James E. Wagner Cultivation Corp., Emerald Health Therapeutics, Inc., INDIVA Limited, The Supreme Cannabis Company, Inc. and TerrAscend Corp. Additionally, the Company has completed bulk purchases and/or off-take agreements with thirteen Licensed Producers securing dried cannabis supply to build MediPharm’s oil inventories for private label sale. The Company also continues to make progress on new partnership agreements with additional Licensed Producers and branded product manufacturers for cannabis private label manufacturing, as well as partnerships to purchase cannabis concentrates for global export for private label and research and development.
About MediPharm Labs Corp.
Founded in 2015, MediPharm Labs is a pioneer in the cannabis industry and has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulations (ACMPR) without first receiving a cannabis cultivation licence. This expert focus on cannabis concentrates from its cGMP (current Good Manufacturing Practices) and ISO standard-built clean rooms and critical environments laboratory, allows MediPharm Labs to work with its established, Health Canada-approved cultivation partners to produce pharmaceutical-grade cannabis oil with a competitive advantage. MediPharm Labs is research-driven and focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. MediPharm Labs provides B2B contract processing of cannabis to Canadian authorized licensed producers and appropriate international growers, supplying integrity-assured cannabis oil to qualified companies for sale under their own brand. In addition, MediPharm Labs will supply raw materials, formulations, processing and packaging for the creation of ready-to-sell advanced derivative products. MediPharm Labs was awarded START-UP OF THE YEAR at the recent Canadian Cannabis Awards hosted by Lift & Co.
Through its subsidiary, MediPharm Labs Australia Pty. Ltd., MediPharm has also completed its application process with the federal Office of Drug Control to extract and import medical cannabis products in Australia.
For further information, please contact:
Laura Lepore, Vice President, Investor Relations & Communications
Telephone: 705-719-7425 ext 216
Email: investors@medipharmlabs.com
Website: www.medipharmlabs.com
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSXV) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
?
CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION:
This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate to, among other things, strong revenue growth, future capacity expansion, expected GMP certification and the establishment of operations in Australia. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; the inability of MediPharm to obtain adequate financing; and the delay or failure to receive regulatory approvals. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, MediPharm assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.
Yeah looks like pretty dismal prospects...lol
I would like to know how is it there isn’t a class action lawsuit for failure to deliver on Triway dividend, it’s been years and we still don’t have in our possession? I don’t care what taxes they have to pay, it is owed to investors NOW!
What exactly do these deuschbags do to earn a paycheck? Seriously, they can’t even seem to execute on growing the damn shrimp...
Supposed lawsuit means diddly squat, and internal lawsuits would mean even less. This company isn't going anywhere and will recover just like it did after party and emerge even stronger with experienced management at the helm.
Definitely should hear something from the company giving a more detailed explanation of whats going on and business as usual. Obviously most of us are holding at present and once panic subsides...time to add.